Background Research biopsies are an increasingly important component of clinical trials, but there are concerns that biopsies may deter patients from participating in research.Patients and methods Patients participating in a single-center study investigating the feasibility of molecular profiling in advanced gastrointestinal cancers were asked to complete a questionnaire regarding their reasons for consenting/declining optional research biopsies and blood samples. These samples were mainly for exploratory translational research and were unlikely to influence patients' treatment.Results One hundred ninety-six (88%) of the 222 patients registered in the study completed the questionnaire. One hundred twenty-six patients (64%) stated they conse...
Abstract Background Biobanks have the potential to offer a venue for chronic disease biomarker disco...
Abstract There are ethical concerns regarding the per-formance of biopsies in patients for research ...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Objective: Research biopsies are increasingly incorporated into phase I oncology trials resulting in...
A growing number of clinical trials incorporate invasive procedures like nondiagnostic tumor biopsie...
BACKGROUND: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
Background: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
As part of the precision medicine initiative, the National Institutes of Health/National Institute o...
Patients consented to biobanking studies typically do not specify research conducted on their sample...
Background: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer t...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer toward...
Purpose: Dramatic advances in genomic technology stand to revolutionize cancer care; however, little...
Objective: This study aimed to discern preferences for receiving somatic molecular profiling (MP) r...
Although both financial and intrinsic conflicts of interest can exist throughout the drug develop-me...
Abstract Background Biobanks have the potential to offer a venue for chronic disease biomarker disco...
Abstract There are ethical concerns regarding the per-formance of biopsies in patients for research ...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Objective: Research biopsies are increasingly incorporated into phase I oncology trials resulting in...
A growing number of clinical trials incorporate invasive procedures like nondiagnostic tumor biopsie...
BACKGROUND: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
Background: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
As part of the precision medicine initiative, the National Institutes of Health/National Institute o...
Patients consented to biobanking studies typically do not specify research conducted on their sample...
Background: Biospecimens for cancer research are commonly sought from people who undergo surgery for...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer t...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer toward...
Purpose: Dramatic advances in genomic technology stand to revolutionize cancer care; however, little...
Objective: This study aimed to discern preferences for receiving somatic molecular profiling (MP) r...
Although both financial and intrinsic conflicts of interest can exist throughout the drug develop-me...
Abstract Background Biobanks have the potential to offer a venue for chronic disease biomarker disco...
Abstract There are ethical concerns regarding the per-formance of biopsies in patients for research ...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...